Document is current
Any future updates will be listed below
-
Authors
Bittner, Beate
Munoz, Javier
Frank, Sabine
Dolton, Michael
Ravanello, Renato
Dembowski, Markus
Clement, Aude
Richter, Wolfgang F.
- License Information
-
More Information
Article History
Accepted: 2 November 2025
First Online: 17 November 2025
Declarations
:
: Beate Bittner, Javier Munoz, Sabine Frank, Michael Dolton, Renato Ravanello, Markus Dembowski, and Aude Clement are employees of F. Hofmann–La Roche/Genentech. Beate Bittner, Javier Munoz, Michael Dolton, Renato Ravanello, Markus Dembowski, and Aude Clement own stock in Roche. Wolfgang F. Richter has received consultant honoraria from Roche and owns stock in Roche. Beate Bittner serves on the board of the Subcutaneous Drug Delivery and Development Consortium.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Beate Bittner was the lead author of the manuscript, led concept development, conducted literature search. Javier Munoz and Wolfgang F. Richter conducted literature search, provided input into the scope and concept, and prepared the figures and tables. Michael Dolton conducted literature search, provided input into the scope and concept. Sabine Frank and Aude Clement provided input into the scope and concept. Renato Ravanello and Markus Dembowski provided technical development expertise. All authors read and approved the final manuscript.
